Senior Site Activation Coordinator - Hybrid (Istanbul)

IQVIA Inc; Fatih; Hybrid; TRY 2,001,000 - 3,752,000; Full time

Benefits offered by this job

Exposure across 21 Therapeutic Areas

Global team across 141 locations

Exposure across various studies

Access to new technologies

Collaborative and vibrant environment

Own your career

Job summary

IQVIA seeks a Senior Site Activation Coordinator to drive feasibility, site activation and maintenance activities for investigational sites at a country level. You will collaborate with the Site Activation Manager, PM team, and other departments to ensure regulatory compliance and timely study progression.

You will prepare, review and track essential documents such as questionnaires, CDAs, regulatory and ethics approvals, and Investigator Pack releases, while maintaining accuracy across systems

Qualifications

• Bachelor’s degree in Life Science or related field.
• Minimum 2 years’ work experience; 1+ year in healthcare.
• Strong interpersonal, communication and organisational skills.
• Ability to work on multiple projects concurrently.

Responsibilities

• Perform feasibility, site activation and maintenance activities for investigative sites.
• Coordinate with Site Activation Manager, Project Management team and others.
• Prepare site documents and track approvals and required documents.
• Update and maintain internal systems, databases, timelines and project plans.

Skills

Interpersonal skills

Communication skills

Organisational skills

Multitasking

Stakeholder management

Education

Bachelor’s Degree in Life Science or related field

Job description

IQVIA seeks a Senior Site Activation Coordinator to drive feasibility, site activation and maintenance activities for investigational sites at a country level. You will collaborate with the Site Activation Manager, PM team, and other departments to ensure regulatory compliance and timely study progression.

You will prepare, review and track essential documents such as questionnaires, CDAs, regulatory and ethics approvals, and Investigator Pack releases, while maintaining accuracy across systems